Clinical Trial Update: Study on Long Term Outcomes of Atazanavir in Antiretroviral-naïve Human Immunodeficiency Virus (HIV) Patients in Real Life Setting

View source ↗

Summary

A completed study evaluating long-term outcomes of initiating atazanavir in antiretroviral-naïve HIV patients in real-world clinical settings.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• HIV Infection

Drugs mentioned

• REYATAZ (atazanavir)

Snippet

Sponsor: Bristol-Myers Squibb | Conditions: HIV | Status: COMPLETED